1. Home
  2. XRTX vs FRSX Comparison

XRTX vs FRSX Comparison

Compare XRTX & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

HOLD

Current Price

$0.57

Market Cap

4.4M

Sector

Health Care

ML Signal

HOLD

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

HOLD

Current Price

$1.00

Market Cap

4.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
XRTX
FRSX
Founded
2011
N/A
Country
Canada
Israel
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.4M
4.7M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
XRTX
FRSX
Price
$0.57
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
32.8K
1.4M
Earning Date
11-17-2025
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$452,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$0.90
52 Week High
$1.41
$9.24

Technical Indicators

Market Signals
Indicator
XRTX
FRSX
Relative Strength Index (RSI) 45.75 20.80
Support Level $0.55 $0.93
Resistance Level $0.60 $1.46
Average True Range (ATR) 0.03 0.10
MACD -0.00 -0.03
Stochastic Oscillator 30.62 11.09

Price Performance

Historical Comparison
XRTX
FRSX

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

Share on Social Networks: